Onconetix, Inc. J4T.MU Stock
Onconetix, Inc. Price Chart
Onconetix, Inc. J4T.MU Financial and Trading Overview
| Onconetix, Inc. stock price | 0.15 EUR |
| Previous Close | 1.04 EUR |
| Open | 1.06 EUR |
| Bid | 1.02 EUR x N/A |
| Ask | 1.07 EUR x N/A |
| Day's Range | 1.06 - 1.06 EUR |
| 52 Week Range | 0.77 - 5.9 EUR |
| Volume | 1.3K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 26.03M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
J4T.MU Valuation Measures
| Enterprise Value | 29.69M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.85161287 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.04 |
Trading Information
Onconetix, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -67.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.9 EUR |
| 52 Week Low | 0.77 EUR |
| 50-Day Moving Average | 0.91 EUR |
| 200-Day Moving Average | 1.3 EUR |
J4T.MU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 15.91M |
| Float | 10.84M |
| Short Ratio | N/A |
| % Held by Insiders | 25.38% |
| % Held by Institutions | 17.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -43.49% |
| Return on Equity (ttm) | -78.37% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -14551688 EUR |
| Net Income Avi to Common (ttm) | -14195813 EUR |
| Diluted EPS (ttm) | -0.87 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.26M EUR |
| Total Cash Per Share (mrq) | 1.27 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.001 |
| Book Value Per Share (mrq) | 1.24 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12258852 EUR |
| Levered Free Cash Flow (ttm) | -8672894 EUR |
Profile of Onconetix, Inc.
| Country | Germany |
| State | OH |
| City | Cincinnati |
| Address | 201 East Fifth Street |
| ZIP | 45202 |
| Phone | 513 620 4101 |
| Website | https://www.bluewatervaccines.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also develops other products that are under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. Blue Water Vaccines, Inc. was incorporated in 2018 and is based in Cincinnati, Ohio.
Q&A For Onconetix, Inc. Stock
What is a current J4T.MU stock price?
Onconetix, Inc. J4T.MU stock price today per share is 0.15 EUR.
How to purchase Onconetix, Inc. stock?
You can buy J4T.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Onconetix, Inc.?
The stock symbol or ticker of Onconetix, Inc. is J4T.MU.
Which industry does the Onconetix, Inc. company belong to?
The Onconetix, Inc. industry is Biotechnology.
How many shares does Onconetix, Inc. have in circulation?
The max supply of Onconetix, Inc. shares is 22.32M.
What is Onconetix, Inc. Price to Earnings Ratio (PE Ratio)?
Onconetix, Inc. PE Ratio is now.
What was Onconetix, Inc. earnings per share over the trailing 12 months (TTM)?
Onconetix, Inc. EPS is -1.01 EUR over the trailing 12 months.
Which sector does the Onconetix, Inc. company belong to?
The Onconetix, Inc. sector is Healthcare.